Heo Bin Yang

Title: Heo Bin Yang - Innovator in Cancer Detection and Treatment

Introduction

Heo Bin Yang is a prominent inventor based in Seoul, South Korea. He is known for his significant contributions to the field of cancer research, particularly through his innovative patent related to antibody technology.

Latest Patents

Heo Bin Yang holds a patent titled "Antibody binding specifically to ECL-2 of claudin 3, fragment thereof, and use thereof." This invention focuses on the use of an antibody that binds specifically to ECL-2 of claudin 3 and its functional fragments. The applications of this antibody include cancer cell detection, diagnosis, imaging, and treatment. The patent highlights the remarkable effects of a characteristic CDR sequence in these uses, including its application in antibody-drug conjugates (ADCs) and CAR-expressing immune cells.

Career Highlights

Heo Bin Yang is associated with Abion Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, particularly in the development of innovative cancer therapies.

Collaborations

He collaborates with notable colleagues, including Young Kee Shin and Sung Youl Hong, who contribute to his research endeavors and the advancement of their shared goals in cancer treatment.

Conclusion

Heo Bin Yang's innovative work in antibody technology represents a significant advancement in cancer detection and treatment. His contributions are paving the way for new therapeutic approaches that could improve patient outcomes in oncology.